Tobramycin

Product NDC: 36000-242
11-digit product format: 360000242
Labeler code: 36000
Product ID: 36000-242_19ade85b-3da4-44af-8ad0-d68d15a48193
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Tobramycin
Dosage form: INJECTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: Baxter Healthcare Corporation
Application: ANDA206965
Marketing category: ANDA
Marketing start: 2016-07-15
Substance: TOBRAMYCIN SULFATE
Active strength: 40 mg/mL
Pharmacologic classes: Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	36000-242	36000-242-05	D	Discontinued by firm		2026-08-10
excluded package	package	36000-242	36000-242-10	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source date	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	36000-242-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	36000-242-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	36000-242-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	36000-242-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	36000-242-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	36000-242-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	36000-242-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	36000-242-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	36000-242-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	36000-242-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	36000-242-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	36000-242-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	36000-242-05	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	36000-242-10	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	36000-242-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	36000-242-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	36000-242-05	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	36000-242-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	36000-242-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	36000-242-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	36000-242-05	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	36000-242-10	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	36000-242-05	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	36000-242-10	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A206965-001	TOBRAMYCIN SULFATE	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP		2016-07-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A206965-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A206965-001	TOBRAMYCIN SULFATE	EQ 40MG BASE/ML	INJECTABLE / INJECTION	AP	2016-07-01	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206965-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206965-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206965-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206965-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206965-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206965-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206965-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206965-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206965-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206965-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206965-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206965-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206965-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206965-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206965-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206965-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206965-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206965-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206965-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A206965-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A206965-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A206965-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A206965-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A206965-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A206965-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A206965-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A206965-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A206965-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A206965-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A206965-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A206965-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A206965-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A206965-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A206965-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A206965-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A206965-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A206965-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A206965-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A206965-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A206965-001	AP	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Tobramycin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
TOBRAMYCIN SULFATE	40 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
HJT0RXD7JK	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
597823	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a9897444-71f6-42af-9b71-4aa77829ade0	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f297c7c1-845a-4369-8c02-c51b92d6ae8e	Product name	3	20240725
551d952d-4ce2-24f0-9ab0-630ad9aae596	Product name	2	20231211
941f67d9-7f03-56d2-750c-36de24f654db	Product name	3	20221117
9cfa145f-dbe9-bc02-83c2-692786ef6676	Product name	9	20210928
2f9713b8-5e7e-bbcc-b364-1b2c27a63796	Product name	4	20210903
32a533bc-01c7-2b9f-bbf7-ecfb0d964277	Product name	4	20210625
9f5124fb-08b0-4c3e-8e12-a1a6ff310cba	Product name	1	20150309
745a62af-e1c0-4ca3-6d6e-2b6455b903be	Product name	1	20140508
9ea85abb-fa68-5da6-ab60-2c7eef579000	Product name	1	20140508
aa1cd319-ece7-51f7-3a9d-52a64f5f4e81	Product name	1	20140508
d029211e-5e6b-725f-3696-ac6ff77da222	Product name	1	20140508
ef5b7aed-2b01-3ba8-5a1c-3bc9c9f03bb1	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
36000-242-01	Tobramycin	1 in 1 CARTON	INJECTION	1	16
36000-242-01	Tobramycin	30 mL in 1 VIAL, MULTI-DOSE	INJECTION	30	16
36000-242-05	Tobramycin	30 mL in 1 VIAL	INJECTION	30	16
36000-242-05	Tobramycin	5 in 1 CARTON	INJECTION	5	16
36000-242-10	Tobramycin	10 in 1 CARTON	INJECTION	10	16
36000-242-10	Tobramycin	30 mL in 1 VIAL	INJECTION	30	16

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
36000-242-01	ML - Milliliter	36000-242	d55d9e95-edb7-4a5e-8fb0-ef21085bb0c9	1	2016-10-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
36000-242	TOBRAMYCIN INJECTION [BAXTER HEALTHCARE CORPORATION]	15	Current NDC, Legacy NDC, 6 package rows	20240922_a9897444-71f6-42af-9b71-4aa77829ade0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tobramycin	TOBRAMYCIN	Baxter Healthcare Corporation	a9897444-71f6-42af-9b71-4aa77829ade0	2023-03-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206965 application number: ANDA206965 ndc (product): 36000-242

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
HJT0RXD7JK	TOBRAMYCIN SULFATE	49842-07-1	TOBRAMYCIN SULFATE
VZ8RRZ51VK	TOBRAMYCIN	32986-56-4	Tobramycin

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
597823	tobramycin 40 MG/ML Injectable Solution	PSN	a9897444-71f6-42af-9b71-4aa77829ade0	16
597823	tobramycin 40 MG/ML Injectable Solution	SCD	a9897444-71f6-42af-9b71-4aa77829ade0	16
597823	tobramycin (as tobramycin sulfate) 40 MG/ML Injectable Solution	SY	a9897444-71f6-42af-9b71-4aa77829ade0	16

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
36000-242-01	36000024201	1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE		2016-07-15	0000-00-00	No	No	Current
36000-242-05	36000024205	30 mL in 1 VIAL	30 ml					Historical
36000-242-10	36000024210	10 in 1 CARTON						Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TOBRAMYCIN Injection, USP	Baxter Healthcare Corporation \| BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED	2023-03-15	HUMAN PRESCRIPTION DRUG LABEL	16